- Home
- WVVI vs ABP Comparison
WVVI vs ABP Comparison
Compare WVVI & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVVI
- ABP
- Stock Information
- Founded
- WVVI 1983
- ABP 2004
- Country
- WVVI United States
- ABP United States
- Employees
- WVVI N/A
- ABP N/A
- Industry
- WVVI Beverages (Production/Distribution)
- ABP Biotechnology: Pharmaceutical Preparations
- Sector
- WVVI Consumer Staples
- ABP Health Care
- Exchange
- WVVI Nasdaq
- ABP Nasdaq
- Market Cap
- WVVI 13.0M
- ABP 15.2M
- IPO Year
- WVVI N/A
- ABP N/A
- Fundamental
- Price
- WVVI $2.55
- ABP $5.93
- Analyst Decision
- WVVI
- ABP Hold
- Analyst Count
- WVVI 0
- ABP 1
- Target Price
- WVVI N/A
- ABP N/A
- AVG Volume (30 Days)
- WVVI 17.2K
- ABP 217.1K
- Earning Date
- WVVI 11-13-2025
- ABP 11-14-2025
- Dividend Yield
- WVVI N/A
- ABP N/A
- EPS Growth
- WVVI N/A
- ABP N/A
- EPS
- WVVI N/A
- ABP N/A
- Revenue
- WVVI $37,366,837.00
- ABP N/A
- Revenue This Year
- WVVI N/A
- ABP N/A
- Revenue Next Year
- WVVI N/A
- ABP N/A
- P/E Ratio
- WVVI N/A
- ABP N/A
- Revenue Growth
- WVVI N/A
- ABP 50.00
- 52 Week Low
- WVVI $2.49
- ABP $4.55
- 52 Week High
- WVVI $7.18
- ABP $153.90
- Technical
- Relative Strength Index (RSI)
- WVVI 28.58
- ABP 90.47
- Support Level
- WVVI $2.50
- ABP $5.34
- Resistance Level
- WVVI $2.90
- ABP $6.14
- Average True Range (ATR)
- WVVI 0.28
- ABP 0.47
- MACD
- WVVI -0.02
- ABP 0.11
- Stochastic Oscillator
- WVVI 1.93
- ABP 94.13
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.